Chocamine By LiveLong Overview & Drug Interactions
Check For Interactions With Chocamine
Supplement: Chocamine by LiveLong
Chocamine Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Chocamine
Cocoa is a plant native to South America, and is the source of cocoa beans, which are used to make chocolate and other products. Cocoa beans are rich in a number of compounds that are believed to have health benefits, including flavonoids, polyphenols, and other antioxidants. In traditional medicine, cocoa is used as a natural remedy for high blood pressure, high cholesterol, and other cardiovascular problems. It is also thought to have anti-inflammatory properties, and it may be helpful in reducing inflammation and swelling in the body.
See More Information Regarding Cocoa| Ingredient Group | cocoa |
|---|---|
| Category | botanical |
Drugs that interact with Chocamine by LiveLong
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 90 |
| UPC/BARCODE | 610074528616 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Chocamine |
100 mg
|
cocoa |
--
|
| Other Ingredients: |
Gelatin
Glycerin
Water
|
|---|
Label Statments:
| General Statements |
- An extract from cocoa, Chocamine can promote many health benefits without the unwanted sugars and fat of chocolate.
- - Increased Energy
- Appetite Suppression
- Improved Mood
- Increased Lipolysis
|
|---|---|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Brand IP Statement(s) |
- Chocamine(R) is a registered trademark of RFI, LLC
Patent # 7,048,941
- Chocamine has been used for mood enhancement and can also be added to a fat loss program.
|
| FDA Statement of Identity |
- DIETARY SUPPLEMENT
|
| Suggested/Recommended/Usage/Directions |
- Suggested Use:
As a dietary supplement, take 1 capsule 1-3 times daily before meals or as directed by your physician.
|
| Precautions |
- WARNING: KEEP OUT OF REACH OF CHILDREN.
- Consult your physician before using this dietary supplement. Do not use this product if you are at risk or are being treated for high blood pressure, heart, kidney, thyroid, or psychiatric disease, difficulty in urinating, prostate enlargement, anxiety, depression, seizure disorder, or stroke.
- Consult your healthcare professional before use if you are taking antidepressants, MAO Inhibitors, or any other prescription drugs.
- Discontinue use and consult your healthcare professional if dizziness, sleeplessness, tremors, nervousness, headache or heart palpitations occur. Consult your healthcare practitioner before beginning any weight loss program.
|
| Formula |
- Chocamine contains theobromine, caffeine, and theophylline, phenylethylamine, tyramine, phenylalanine, tryptophan, and tyrosine.
|
Brand Information
See all products by this brand
| Manufactured For and Distributed By | |
|---|---|
| Name | LIVELONG NUTRITION(TM) |
| City | Piedmont |
| State | SC |
| Web Address | www.livelongsupplements.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.